TNF-α regulating interleukin-33 induces acute pancreatic inflammation in rats

Annals of Clinical and Laboratory Science

Volumn 46, Issue 1, 2016, Pages 54-59

  Jiang, Yong ^a   An, Yong ^a   Jiang, Danqian ^b   Wu, Baoqiang ^a   Yang, Yue ^a   Sun, Donglin ^a  

^a The 1st people's hospital of Changzhou   (China)

^b People's Hospital of Wujin   (China)

Author keywords

Acute pancreatitis; Interleukin 33; TNF

Indexed keywords

INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MESSENGER RNA; PROTEIN; ST2 PROTEIN; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; ST2 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APACHE; ARTICLE; BLEEDING; CELL INFILTRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BLOOD; DEMOGRAPHY; DISEASE MODEL; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADULT; AGED; ANIMALS; DEMOGRAPHY; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-33; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREAS; PANCREATITIS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962308628     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. De Waele JJ. Acute pancreatitis. Curr Opin Crit Care. 2014. 20(2): 189-95.
2. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin- 1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005. 23(5): 479-90.
3. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol. 2011. 186(4): 2523-8.
4. Jung MY, Smrz D, Desai A, et al. IL-33 induces a hyporesponsive phenotype in human and mouse mast cells. J Immunol. 190(2): 531-8.
5. Sabatino G, Nicoletti M, Neri G, et al. Impact of IL -9 and IL-33 in mast cells. J Biol Regul Homeost Agents. 2012. 26(4): 577-86.
6. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood. 2009. 113(7): 1526-34.
7. Suzukawa M, Iikura M, Koketsu R, et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol. 2008. 181(9): 5981-9.
8. Bouffi C, Rochman M, Zust CB, et al. IL-33 markedly activates murine eosinophils by an NF-kappaB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J Immunol. 2013. 191(8): 4317-25.
9. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood. 2009. 113(7): 1526-34.
10. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008. 121(6): 1484-90.
11. Guo Z, Wu J, Zhao J, et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma. 2014: 1-7.
12. Lloyd CM. IL-33 family members and asthma-bridging innate and adaptive immune responses. Curr Opin Immunol. 22(6): 800-6.
13. Zhao J, Wei J, Mialki RK, et al. F-box protein FBXL19- mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat Immunol. 2012. 13(7): 651-8.
14. Shadie AM, Herbert C, Kumar RK. Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33. Clin Exp Immunol. 177(2): 491-9.
15. Talabot-Ayer D, Martin P, Seemayer CA, et al. Immunemediated experimental arthritis in IL-33 deficient mice. Cytokine. 2014. 69(1): 68-74.
16. Kamradt T, Drube S. A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis. Arthritis Res Ther. 2013. 15(3): 115.
17. Hueber AJ, Alves-Filho JC, Asquith DL, et al. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol. 2011. 41(8): 2229-37.
18. Theoharides TC, Zhang B, Kempuraj D, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A. 107(9): 4448-53.
19. Nunes T, 0000-0003-2134-4171 AO, Bernardazzi C, 0000- 0003-4774-902X AO, de Souza HS, 0000-0002-3647-7324 AO. Interleukin-33 and inflammatory bowel diseases: lessons from human studies. Mediators Inflamm. 2014. 2014: 423957.
20. Pastorelli L, De Salvo C, Cominelli MA, Vecchi M, Pizarro TT. Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation. Therap Adv Gastroenterol. 4(5): 311-23.
21. Beltran CJ, Nunez LE, Diaz-Jimenez D, et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010. 16(7): 1097-107.
22. Masamune A, Watanabe T, Kikuta K, Satoh K, Kanno A, Shimosegawa T. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 299(4): G821-32.
23. Nishida A, Andoh A, Imaeda H, Inatomi O, Shiomi H, Fujiyama Y. Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut. 2010. 59(4): 531-41.
24. Schmieder A, Multhoff G, Radons J. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells. Cytokine. 2012. 60(2): 514-21.
25. Sesti-Costa R, Silva GK, Proenca-Modena JL, et al. The IL-33/ ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J Immunol. 2013. 191(1): 283-92.
26. Ouziel R, Gustot T, Moreno C, et al. The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. Am J Pathol. 2012. 180(6): 2330-9.
27. Kempuraj D, Twait EC, Williard DE, Yuan Z, Meyerholz DK, Samuel I. The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS One. 2013. 8(2): e56866.
28. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013. 62(1): 102-11.
29. Tang S, Huang H, Hu F, et al. Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis. Clin Dev Immunol. 2013. 2013: 985301.
30. Tang Y, Guan Y, Liu Y, Sun J, Xu L, Jiang Y. The role of the serum IL-33/sST2 axis and inflammatory cytokines in chronic obstructive pulmonary disease. J Interferon Cytokine Res. 34(3): 162-8.
31. Wang J, Cai Y, Ji H, et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res. 2012. 32(6): 248-53.
32. Matsuyama Y, Okazaki H, Hoshino M, et al. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1beta signaling and a poor clinical response. Rheumatol Int. 2012. 32(5): 1397-401.
33. Balato A, Di CR, Canta L, et al. IL-33 is regulated by TNFalpha in normal and psoriatic skin. Arch Dermatol Res. 2014. 306(3): 299-304.
34. Taniguchi K, Yamamoto S, Hitomi E, et al. Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis. J Investig Allergol Clin Immunol. 2013. 23(6): 428-34.
35. Demyanets S, Kaun C, Pentz R, et al. Components of the interleukin- 33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol. 2013. 60: 16-26.
36. Su Z, Lin J, Lu F, et al. Potential autocrine regulation of interleukin- 33/ST2 signaling of dendritic cells in allergic inflammation. Mucosal Immunol. 2013. 6(5): 921-30.
37. Kempuraj D, Khan MM, Thangavel R, Xiong Z, Yang E, Zaheer A. Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J Neuroimmune Pharmacol. 2013. 8(3): 643-50.
38. Lin J, Zhang L, Zhao G, et al. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium. PLoS One. 2013. 8(4): e60963.
39. Zhang H, Neuhofer P, Song L, et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest. 2013. 123(3): 1019-31.
40. De Waele JJ, Blot S. The value of IL-6 in predicting the severity of acute pancreatitis. J Clin Gastroenterol. 2007. 41(5): 534; author reply 534-5.
41. Wu H, Yang S, Wu X, et al. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochem Biophys Res Commun. 2014. 450(1): 110-6.